PITCH US
Portfolio
Collective
Community
Team
Insights
Submit pitch deck
Submit pitch deck

Any questions?

hello@byfounders.vc
Download our Term Sheet
Events
FAQ
Jobs
Seeking interns!
Privacy policy/GDPR
Whistleblower
Portfolio
November 17, 2022

Proper Secures €3 Million to Continue its European Expansion

Proptech startup Proper has just raised an additional €3 million in new funding. The Copenhagen-based team is aiming to transform the way we live, facilitating greater harmony between landlords and tenants.

No items found.
Proper Secures €3 Million to Continue its European Expansion
No items found.
More about the author(s)
No items found.
More about the author(s)
No items found.

Related

All news & insights
All news & insights
Centralize your Medical History with Livv Health's AI-enhanced 'Medical CV'
June 24, 2024

Centralize your Medical History with Livv Health's AI-enhanced 'Medical CV'

Livv revolutionizes healthcare by consolidating fragmented medical records into a single, accessible platform, enabling better patient care through comprehensive health data and improved doctor-patient communication.

Portfolio
Centralize your Medical History with Livv Health's AI-enhanced 'Medical CV'
June 24, 2024

Centralize your Medical History with Livv Health's AI-enhanced 'Medical CV'

Livv revolutionizes healthcare by consolidating fragmented medical records into a single, accessible platform, enabling better patient care through comprehensive health data and improved doctor-patient communication.

Portfolio
External
Qvin's Q-Pad receives FDA clearance
January 8, 2024

Qvin's Q-Pad receives FDA clearance

In early January of 2024, Qvin made history; the FDA clearance of its Q-Pad and A1c Test marked the first FDA approval for menstrual blood health testing.

Portfolio
Qvin's Q-Pad receives FDA clearance
January 8, 2024

Qvin's Q-Pad receives FDA clearance

In early January of 2024, Qvin made history; the FDA clearance of its Q-Pad and A1c Test marked the first FDA approval for menstrual blood health testing.

Portfolio
External
Why we Invested in: MEINE ERDE
January 15, 2024

Why we Invested in: MEINE ERDE

Unveiling sustainable end-of-life solutions with MEINE ERDE, transforming death care to honor environmental values and personal dignity.

Portfolio
Why we Invested in: MEINE ERDE
January 15, 2024

Why we Invested in: MEINE ERDE

Unveiling sustainable end-of-life solutions with MEINE ERDE, transforming death care to honor environmental values and personal dignity.

Portfolio
External

Sign up to our newsletter.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Get access to exclusive insights from our community of world-class founders and operators, delivered quarterly to your inbox. We process your personal data in accordance with our privacy policy.

Follow us

Legal